Home » GENIZON BIOSCIENCE LICENSES CROHN'S DISEASE GENEMAP TO GENENTECH
GENIZON BIOSCIENCE LICENSES CROHN'S DISEASE GENEMAP TO GENENTECH
Genizon BioSciences announced a license and collaboration agreement with Genentech, Inc. Genizon grants Genentech an exclusive license to Genizon's GeneMap of disease-associated genes generated from a whole genome association study of Crohn's disease patients from the Quebec Founder Population. Bionity (http://www.bionity.com/news/e/56959)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May